bpc 157 for degenerative disc disease I get asked about BPC-157 every single week in my clinic. And honestly? I love that my patients are curious about this. The research is fascinating. The rodent data is genuinely interesting Orthopedic Use of BPC-157 -

That peptide became exenatide in around 2005

$550 Includes medication, syringes, alcohol pads, and shipping

BPC 157 has shown low toxicity in animal studies, but long-term human safety data remain limited

Pain levels, functional capacity, subjective improvement feelings

For Canadian researchers, the practical takeaways: AOD-9604 isolates lipolytic activity without engaging GH receptors or affecting IGF-1 Tesamorelin activates the full GH axis through pituitary release of endogenous GH Both have substantive published research bases with different shapes Choice depends on whether isolated vs full-axis GH biology effects are the research goal Same quality framework Janoshik third-party testing applies to both For continued reading, see What Is AOD-9604